{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:23:07Z","timestamp":1720570987020},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1053\/j.seminhematol.2024.06.001","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T07:54:57Z","timestamp":1720511697000},"page":"139-141","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Updates on the biology of chronic lymphocytic leukemia: introductory editorial"],"prefix":"10.1053","volume":"61","author":[{"given":"Elisa","family":"ten Hacken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Eichhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1053\/j.seminhematol.2024.06.001_bib0001","first-page":"143","article-title":"Role of the tumor microenvironment in CLL pathogenesis","volume":"61","author":"Vom Stein","year":"2023","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.06.001_bib0002","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.seminhematol.2024.02.001","article-title":"Metabolic reprogramming in the CLL TME; potential for new therapeutic targets","volume":"61","author":"Simon-Molas","year":"2024","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.06.001_bib0003","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1053\/j.seminhematol.2024.04.001","article-title":"The complexities of T-cell dysfunction in chronic lymphocytic leukemia","volume":"61","author":"Camerini","year":"2024","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.06.001_bib0004","first-page":"173","article-title":"Biological, prognostic, and therapeutic impact of the epigenome in CLL","volume":"61","author":"Maiques-Diaz","year":"2023","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.06.001_bib0005","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/j.seminhematol.2024.03.001","article-title":"miRNA Biology in Chronic Lymphocytic Leukemia","volume":"61","author":"Bayraktar","year":"2024","journal-title":"Semin Hematol."},{"issue":"3","key":"10.1053\/j.seminhematol.2024.06.001_bib0006","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/j.seminhematol.2024.05.002","article-title":"Lessons learned from the E\u00b5-TCL1 mouse model of CLL","volume":"61","author":"Floerchinger","year":"2024","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.06.001_bib0007","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.seminhematol.2024.03.003","article-title":"Mouse models of CLL: In vivo modeling of disease initiation, progression, and transformation","volume":"61","author":"Chen","year":"2024","journal-title":"Semin Hematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2024.06.001_bib0008","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1172\/JCI11092","article-title":"Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism","volume":"107","author":"Burger","year":"2001","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.06.001_bib0009","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2024.06.001_bib0010","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2643-3230.BCD-22-0029","article-title":"Extracellular Vesicle Secretion by Leukemia Cells In Vivo Promotes CLL Progression by Hampering Antitumor T-cell Responses","volume":"4","author":"Gargiulo","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"4","key":"10.1053\/j.seminhematol.2024.06.001_bib0011","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ccell.2016.09.007","article-title":"LYN Kinase in the Tumor Microenvironment Is Essential for the Progression of Chronic Lymphocytic Leukemia","volume":"30","author":"Nguyen","year":"2016","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1053\/j.seminhematol.2024.06.001_bib0012","first-page":"2427","article-title":"Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug","volume":"118","author":"Ramsay","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2024.06.001_bib0013","article-title":"High-dimensional single-cell definition of CLL T cells identifies Galectin-9 as novel immunotherapy target","author":"Cid","year":"2023","journal-title":"bioRxiv"},{"issue":"11","key":"10.1053\/j.seminhematol.2024.06.001_bib0014","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","article-title":"Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia","volume":"44","author":"Kulis","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.06.001_bib0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","article-title":"Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia","volume":"26","author":"Landau","year":"2014","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1053\/j.seminhematol.2024.06.001_bib0016","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","article-title":"The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia","volume":"24","author":"Beekman","year":"2018","journal-title":"Nat Med"},{"issue":"8","key":"10.1053\/j.seminhematol.2024.06.001_bib0017","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med"},{"issue":"24","key":"10.1053\/j.seminhematol.2024.06.001_bib0018","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1053\/j.seminhematol.2024.06.001_bib0019","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1158\/0008-5472.CAN-12-0803","article-title":"Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia","volume":"72","author":"Baer","year":"2012","journal-title":"Cancer Res"},{"issue":"10","key":"10.1053\/j.seminhematol.2024.06.001_bib0020","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1073\/pnas.102181599","article-title":"Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression","volume":"99","author":"Bichi","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.06.001_bib0021","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/2643-3230.BCD-22-0082","article-title":"In vivo modeling of CLL transformation to Richter's syndrome reveals convergent evolutionary paths and therapeutic vulnerabilities","volume":"4","author":"Ten Hacken","year":"2023","journal-title":"Blood Cancer Discov"},{"issue":"2","key":"10.1053\/j.seminhematol.2024.06.001_bib0022","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ccr.2011.06.029","article-title":"Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia","volume":"20","author":"Kikushige","year":"2011","journal-title":"Cancer Cell"},{"issue":"20","key":"10.1053\/j.seminhematol.2024.06.001_bib0023","doi-asserted-by":"crossref","first-page":"5463","DOI":"10.1182\/blood-2010-12-324210","article-title":"A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease","volume":"117","author":"Bagnara","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2024.06.001_bib0024","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1038\/leu.2013.131","article-title":"Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapy","volume":"27","author":"Herman","year":"2013","journal-title":"Leukemia"},{"issue":"13","key":"10.1053\/j.seminhematol.2024.06.001_bib0025","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1158\/0008-5472.CAN-17-4004","article-title":"Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses","volume":"78","author":"Vaisitti","year":"2018","journal-title":"Cancer Res"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196324000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:19:08Z","timestamp":1720531148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196324000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0037196324000714"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.06.001","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on the biology of chronic lymphocytic leukemia: introductory editorial","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2024.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}